Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.

High response rates in patients with metastatic melanoma have been achieved with combination chemoimmunotherapy. A response rate of 62% in 45 patients has been reported for treatment with dacarbazine, bleomycin, vincristine, lomustine (BOLD) plus interferon alpha (IFN-alpha). We conducted a multicen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Punt, C. J., van Herpen, C. M., Jansen, R. L., Vreugdenhil, G., Muller, E. W., de Mulder, P. H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 1997
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2223935/
https://ncbi.nlm.nih.gov/pubmed/9231931
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak